RADIOTHERAPY AND ICRF 159 (NSC 129 943) IN TREATMENT OF INOPERABLE SOFT-TISSUE SARCOMA

被引：7

作者：

RHOMBERG, W

HELLMANN, K

RYALL, RDH

机构：

[1] MED HSCH HANOVER,ABT STRAHLENTHERAPIE & SPEZIELLE ONKOL,KARL-WIECHERT ALLEE 9,3 HANOVER,WEST GERMANY

[2] MED HSCH HANOVER,DEPT KLIN RADIOL,3 HANOVER,WEST GERMANY

[3] IMPERIAL CANC RES FUND,CANC CHEMOTHERAPY DEPT,LONDON,ENGLAND

[4] CLATTERBRIDGE HOSP W,LIVERPOOL REG RADIOTHERAPY CTR,BEBINGTON,CHESHIRE,ENGLAND

来源：

关键词：

D O I：

10.1055/s-0028-1108151

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2438 / &

共 24 条

[11]

HELLMANN K, 1973, LEUKAMIEN MALIGNE LY

[12]

Inoue T, 1973, Nihon Igaku Hoshasen Gakkai Zasshi, V33, P496

[13]

NEWTON K A, 1969, Clinical Radiology, V20, P19, DOI 10.1016/S0009-9260(69)80048-6

[14]

PATERSON R, 1963, TREATMENT MALIGNANT, P406

[15]

PERRY H, 1962, CANCER, V15, P179, DOI 10.1002/1097-0142(196201/02)15:1<179::AID-CNCR2820150125>3.0.CO

[16]

2-B

[17]

PRITCHARD DJ, 1974, CANCER-AM CANCER SOC, V33, P888, DOI 10.1002/1097-0142(197403)33:3<888::AID-CNCR2820330339>3.0.CO

[18]

2-C

[19]

SALSBURY AJ, 1974, CANCER RES, V34, P843

[20] MODE OF ACTION OF CYTOSTATIC AGENT ICRF-159 [J].

SHARPE, HBA ;

FIELD, EO ;

HELLMANN, K .